Gene Therapy--Industry Impact (Technical Insights)


Regular Price: USD 4,950.00

Special Price USD 3,465.00

30% OFF

* Required Fields

Regular Price: USD 4,950.00

Special Price USD 3,465.00


Be the first to review this product

This research service discusses global advances in the field of gene therapy.

Table of Contents

Gene Therapy--Industry Impact (Technical Insights), Executive SummaryScope and MethodologyScopeMethodologyIntroduction and History of Gene TherapyIntroductionHistory of Gene TherapyGene Therapy--Industry Impact (Technical Insights), Technology and Applications ViewpointTechnology PrimerGene delivery--Vectors; Vehicles; Chemical and Physical MethodsDNA VaccinesAdditional ApproachesApplications Analysis and TrendsTargets Closest to MarketOcular Disorders--Macular Degeneration And RetinopathyDiabetesCystic FibrosisRheumatoid ArthritisTypes of DisordersCoronary Artery DiseasePeripheral Artery DiseaseCancerDNA VaccinesAssessment of Stakeholder Innovation and Technology Transfer Opportunities--Influential Market FactorsMergers and Acquisitions AnalysisRegulatory and Political Factors; Industry TrendsGene Therapy--Industry Impact (Technical Insights), Technology Adoption Factor AnalysisRegulatory HurdlesSafety Issues and Regulatory BarriersClinical TrialsTechnology or Product Development Restraints and Competing TechnologiesTechnical BarriersLack of Investor ConfidenceGene Patents; Cost and Other BarriersStem Cells and Other Cellular TherapiesAnalysis of DriversAnalysis of Funding SourcesFeatures and Benefits of Gene TherapyAdoption Drivers for Gene TherapyGene Therapy--Industry Impact (Technical Insights), Assessment of Innovations and OpportunitiesInnovative Developments in North America--Gene TherapyTargeting Cancer Cells with Antibody/Gene/Liposome NanocomplexPolymer Delivers IL-12 Gene Therapy for CancerGene Therapy Promotes Blood Vessel Growth in Peripheral Artery DiseaseLentiviral Vectors in Development p53 Gene Therapy for Esophageal CancerCollagen Used as Target for Cancer Gene TherapyNanotechnology Gene Therapy for Prostate CancerMicrobubbles Release Therapeutic Genes with UltrasoundAutoantigen-Plasmid Drug Promising against MSZinc-Finger Protein Agent for Diabetic NeuropathyGene Therapy for Epilepsy and Parkinson’s DiseaseGene Therapy for OsteoarthritisNaked DNA for Cancer Gene TherapyBare Metal Stents Deliver Gene Therapy to Treat Heart DiseaseGene Immunotherapy--T Cells Transformed into Tumor Fighting CellsEmphysema Gene TherapyHedgehog Agonist Gene for Diabetic Wound HealingNanoparticles for DNA DeliveryFGF Gene Therapy for Myocardial IschemiaNeurturin Gene Therapy for Parkinson’s Disease in Phase II TrialsLight-Activated Gene Therapy Targets Knee Injuries; Other Tissue RepairNew Lipid Molecule Holds Promise for Gene TherapyAdditional CompaniesInnovative Developments in North America--DNA VaccinesFlu DNA Vaccine Candidate Delivered via Needle-Free InjectionDOGS Cation Compound Enhances DNA VaccinesShort ISS DNA Sequences Stimulate Immune ResponsesCell-Free Production of DNA for Flu VaccineDNA Bird Flu Vaccine Protects Lab AnimalsDNA West Nile Vaccine Triggers Immune Response in Human SubjectsHIV VaccinesLeukemia Vaccine Uses Tumor Cells Transfected with GM-CSF GeneAdenoviral TB VaccineClinical Trial for Ebola VaccineInnovative Developments in Europe--Gene TherapyGene Therapy for Critical Limb IschemiaInterferon Vector for Cutaneous LymphomaBelgian and Dutch Companies Seek Spinal Gene TherapiesGene Therapy Appears to Cure Myeloid Disease in Human SubjectsAdditional CompaniesInnovative Developments in Europe--DNA VaccinesAdoptive Cell Therapy for Melanoma VaccineE6 and E7 Genes in HPV Vaccine Clinical TrialsVaccine for Kidney CancerHIV VaccinesInnovative Developments in the Asia Pacific RegionGendicine p53 Gene Therapy Follow-upGene Therapy Successfully Treats Hemophilia Hepatocyte Growth Factor for Liver and Circulatory DisordersDNA Ointment for Atopic DermatitisGene Therapy--Industry Impact (Technical Insights), Patents and Database of Key Industry ParticipantsPatentsKey Patents (2005)Key Patents (2006)Database of Key Industry ParticipantsCorporate SectorLaboratories and UniversitiesGene Therapy--Industry Impact (Technical Insights), Decision Support DatabaseDatabase TablesTotal Healthcare Expenditure--World (2002 to 2012)Government Healthcare Expenditure--World (2002 to 2012)Private Healthcare Expenditure--World (2002 to 2012)

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.